A new injectable medicine is giving hope to people with asthma by helping them breathe better. The drug, called dupilumab ...
Omalizumab had the greatest risk for adverse effects and dupilumab had the most favorable safety profile among biologics for patients with asthma, according to an abstract presented at the CHEST ...
An anti-inflammation injectable drug called dupilumab can reduce mucus buildup and improve breathing among asthma patients, a ...
A medication used to treat asthma can now be used to help people with food allergies avoid severe reactions, the U.S. Food and Drug Administration said Friday. Xolair, the brand name for the drug ...
Patients who depended on oral corticosteroids to care for their severe asthma experienced improvements in asthma control ...
Down-titrating vial concentrations when restarting subcutaneous allergen immunotherapy after treatment gaps may help lower ...
OKLAHOMA CITY (KFOR) — Next month, Oklahomans with severe asthma who are insured with BlueCross and BlueShield of Oklahoma (BCBSOK), may have to give themselves life-saving shots at home after a ...
Blue Cross Blue Shield is changing how some asthma injections are given, sparking concerns from doctors. Blue Cross Blue Shield (BCBS), under its parent company Health Care Service Corporation, is ...
Intranasal epinephrine is effective and comparable to epinephrine injection products for severe allergic reactions.
The National Institute for Health and Care Excellence (NICE) is recommending the injectable biologic dupilumab (Dupixent, Sanofi) as a maintenance therapy for uncontrolled asthma as an alternative to ...
Hosted on MSN
Oklahoma's largest health insurer is putting its own profits ahead of patients | Opinion
Oklahoma's largest health insurer recently made a drastic change that will limit treatment options for people battling severe asthma.Blue Cross Blue Shield of Oklahoma, which covers more than 800,000 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results